Daniel B. Dix,Kenneth S. Graham,Douglas Kamen,Scott M. Walsh
申请号：
US14861565
公开号：
US20160002341A1
申请日:
2015.09.22
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-6 receptor (hIL-6R). The formulations may contain, in addition to an anti-hIL-6R antibody, at least one amino acid, at least one sugar, and/or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.
